Experimental antiarteriosclerotic effects of calcium antagonists.
Fleckenstein
A
A
Physiological Institute, University of Freiburg, Federal Republic of Germany.
Fleckenstein-Grün
G
G
Frey
M
M
Thimm
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001158:Arteries / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D001161:Arteriosclerosis / Q000139:chemically induced / Q000517:prevention & control*; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002473:Cell Wall / Q000187:drug effects / Q000502:physiology; D004095:Dihydropyridines / Q000494:pharmacology; D006801:Humans; D008854:Microscopy, Electron; D008875:Middle Aged; D051381:Rats; D011918:Rats, Inbred SHR
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D002118:Calcium